In CRC, several mechanisms work to skew the normal Notch-ATOH1 balance to favor Notch activation, including silencing of ATOH1 by genetic and epigenetic mechanisms (Bossuyt et al., 2009). Here, ATOH1 is linked to colorectal carcinoma.